Results 81 to 90 of about 63,264 (143)

The Effects of High Fat, Low Carbohydrate and Low Fat, High Carbohydrate Diets on Tumor Necrosis Factor Superfamily Proteins and Proinflammatory Cytokines in C57Bl/6 Mice

Iranian Journal of Allergy, Asthma and Immunology, 2014
There has been considerable inconsistency regarding the potential relationship between dyslipidemia and bone metabolism. The inflammatory stimulation through the receptor activator of the nuclear factor kappa-B ligand (RANKL)/ receptor activator of the ...
Mahshid Sirjani, Foroogh Azam Taleban, Azita Hekmatdoost, Zohreh Amiri, Michael Pellizzon, Mehdi Hedayati, Katayoon Bidad, Raheleh Shokouhi Shoormasti, Zahra Pourpak   +8 more
doaj  

Evaluation of Osteoprotegerin (OPG) and Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Biomarker Concentrations in the Saliva of Patients with Periodontitis and Depression. [PDF]

Clin Exp Dent Res
Esmaeilnejad A, Lafzi A, Neishabouri SM, Bigham MM.   +3 more
europepmc   +1 more source

A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report. [PDF]

BMC Nephrol, 2020
Horikoshi K, Sakai N, Yamamoto N, Ogura H, Sato K, Miyagawa T, Kitajima S, Toyama T, Hara A, Iwata Y, Shimizu M, Furuichi K, Wada T.   +12 more
europepmc   +1 more source

Evaluating Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) and Osteoprotegerin (OPG) expression during canine retraction: A comparison between periodontal distraction versus conventional retraction. [PDF]

J Orthod Sci
Eissa O, Yousif A, El-Bialy T, Elmarhoumy S, Ramadan S, Farag M.   +5 more
europepmc   +1 more source

Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes. [PDF]

PeerJ, 2020
Wang Z, Weng Y, Ishihara Y, Odagaki N, Ei Hsu Hlaing E, Izawa T, Okamura H, Kamioka H.   +7 more
europepmc   +1 more source

Receptor activator of nuclear factor-kappa B ligand-derived microglia healing peptide 1-AcN inhibits osteoarthritis progression in mice. [PDF]

Arthritis Res Ther
Fukuda Y, Shimamura M, Etani Y, Noguchi T, Kurihara T, Goshima A, Miura T, Hirao M, Ochiai N, Ju N, Sugimoto A, Kanamoto T, Nakata K, Okada S, Ebina K.   +14 more
europepmc   +1 more source

Global knowledge mapping of receptor activator of nuclear factor kappa-B ligand in osteoporotic fractures: a bibliometric analysis (2001-2024). [PDF]

Front Mol Biosci
Lu S, Shen H, Li M, Luo Y, Sun H, Zhao X, Chen J, Bai R, Han P, Zha Y, Jiang X.   +10 more
europepmc   +1 more source

RNA interference-mediated osteoprotegerin silencing increases the receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio and promotes osteoclastogenesis. [PDF]

World J Stem Cells
Wei SG, Chen HH, Xie LR, Qin Y, Mai YY, Huang LH, Liao HB.   +6 more
europepmc   +1 more source

Combined effect of micro-osteoperforation and vibration on interleukin-1B, receptor activator of nuclear factor kappa-B ligand, C-C motif chemokine ligand 2, and tumor necrosis factor-alpha in orthodontic patients: A parallel-design randomized clinical trial. [PDF]

Dent Res J (Isfahan)
Gholamrezayi E, Sarmadi S, Samimi SM, Ghadirian H.   +3 more
europepmc   +1 more source

Early and multiple doses of zoledronate mitigates rebound bone loss following withdrawal of receptor activator of nuclear factor kappa-B ligand inhibition. [PDF]

J Bone Miner Res
Kim AS, Taylor VE, Castro-Martinez A, Dhakal S, Zamerli A, Mohanty ST, Xiao Y, Simic MK, Pantalone A, Chu J, Cheng TL, Croucher PI, Center JR, Girgis CM, McDonald MM.   +14 more
europepmc   +1 more source